Posters
Onconephrology: Emerging Biomarkers, Preclinical Models, Clinical Challenges, and Therapeutic Strategies
October 22, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Cancer-Associated Kidney Alterations: Current and Novel Biomarkers
Transcriptionally Reprogrammed Circulating CD4 and CD8 T Cells in Post-Transplant Cancer
Early Urinary Biomarker to Identify Tolerable Radioligand Therapy Dosing: A Pilot Study
DNA Damage Response Promotes Checkpoint-Specific Upregulation of PVR, CD47, and PD-L1 Through Distinct Regulatory Mechanisms in Kidney Embryonic Cells
Clinical Mitigation Strategies of Immune Checkpoint Inhibitor-Induced Nephrotoxicity Evaluated in a Humanized Mouse Model
Intrarenal Vascular Resistance Modifies the Prognostic Meaning of Renal Stiffness for Kidney Risk After Hematopoietic Stem Cell Transplantation
Cisplatin Immunotoxicity in Nickel-Responsive CD4 T Cells, Mouse Kidney, and Urine of Patients with Cancer
THY1/CD90: An Early Kidney Injury Biomarker in Cisplatin-Treated Patients with Cancer
Defining the Cytoskeletal Interactome of the Proximal Tubule: A Network Analysis of Payload-Specific Antibody-Drug Conjugate Nephrotoxicity
High-Resolution Spatial Transcriptomics May Detect Micrometastasis from Renal Cell Carcinoma in "Normal"-Appearing Tissue
Complement C3 Is a Hypoxia-Inducible Gene Associated with Poor Prognosis in Hospitalized Patients with Kidney Cancer and New Dialysis Requirement
Immunocompetent Murine Neuroblastoma Induces Kidney Fibrosis
Not Just an Infection: Upper Tract Urothelial Carcinoma Presenting as Psoas Abscess
Monoclonal Membranous Nephropathy as the Initial Manifestation of Chronic Lymphocytic Leukemia
Dialysis Within 11 Months: IgA Myeloma Cast Nephropathy
Atypical Renal Lymphocytic Infiltrate: A Rare Kidney Biopsy Finding After Chimeric Antigen Receptor-T Cell Therapy for Chronic Lymphocytic Leukemia
Fibrillar IgG-Lambda Deposition in Chronic Lymphocytic Leukemia
Reversible Kidney Impairment Secondary to Lenalidomide-Associated Thyroid Dysfunction: A Case Report
Thrombotic Microangiopathy (TMA) After Tumor-Infiltrating Lymphocytes (TIL) Therapy for Metastatic Melanoma
Tubulointerstitial Nephritis Associated with IgG4-Related Disease
Paraneoplastic Syndrome of Inappropriate Antidiuretic Hormone Secretion as a Harbinger of Metastatic Merkel-Cell Carcinoma: An Electrolyte Clue to Disease Progression
Gemcitabine-Induced Thrombotic Microangiopathy Refractory to Complement Inhibition
Type 1 Cryoglobulinemic Glomerulonephritis with Vasculitis: Rapid Resolution of AKI with Treatment Aimed at Underlying Clonal Disorder
Pseudohypervitaminosis D in Multiple Myeloma
Complement-Mediated Renal Thrombotic Microangiopathy Associated with Anti-Vascular Endothelial Growth Factor and Immune Checkpoint Inhibitor Therapy Successfully Treated with Eculizumab
Cisplatin-Associated Isolated Persistent Type 1 (Distal) Renal Tubular Acidosis: A Rare Manifestation of Tubular Toxicity
Aprocitentan for Antivascular Endothelial Growth Factor Signaling Pathway Inhibitor-Induced Hypertension and/or Proteinuria
Long-Term Renal Safety of 177Lu-Dotatate in Patients with CKD: A Five-Year Follow-Up Study